Search

 

Professional Education
Delayed Diagnosis of Sepsis (Claims Corner CME)
In reviewing closed malpractice claims, The Doctors Company has identified delayed diagnosis and treatment of sepsis as a serious problem that can result in significant morbidity and mortality. This article highlights the importance of timely recognition of symptoms that point to a diagnosis of sepsis, and the need for quick initiation of treatment. Factors contributing to the delayed diagnosis and treatment of sepsis are discussed, including clinical judgment errors such as failure to note the importance of significant clinical symptoms, failure to seriously consider sepsis as high on the differential diagnosis, failure to use a sepsis recognition tool as an adjunct to the exam, failure to order appropriate tests to rule out sepsis before assuming another diagnosis, and failure to admit the patient to the hospital for treatment.

Professional Education
Module 4: Recognition, Diagnosis, and Treatment of Substance Use Disorder (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will be shown strategies for recognizing substance use disorder (SUD) and opioid use disorder (OUD). Refamiliarize yourself with screening for fentanyl. Provide valuable pharmacological and nonpharmacological resources to connect patients to treatment for addiction. Discuss individualized treatment plans that are tailored to specific patient needs when treating OUD. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

Dec 21, 2023
Medical Malpractice and the Volunteer Team Physician
Michael C. Koester, MD, Slocum Center for Orthopedic and Sports Medicine
Community physicians have long served as local high school team physicians. Michael C. Koester, MD, discusses the potential liability risks.
From The Doctor’s Advocate

Aug 30, 2021
Preparing for Genomic Medicine: Implications for Medical Practice and Public Policy
Elizabeth Y. Healy, Assistant Vice President, Government and Community Relations, The Doctors Company; Robert Nussbaum, MD, Chief Medical Officer, Chantelle Schenning, PhD, MHA, Head of Public Policy, and Kristine Ashcraft, BS, MBA, Head of Pharmacogenomics, Invitae Corporation
As genomic medicine becomes part of standard clinical care, we learn more about its far-reaching implications on the medical profession, public policy, and the legal system.
From The Doctor’s Advocate

Dental Malpractice Insurance Coverage
Industry-leading malpractice insurance for dentists, including coverage for dental assistants and hygienists at no additional cost and coverage for all dental specialties.

New Mexico Legislative Update
The medical liability landscape in New Mexico has seen significant changes over the past few years. Legislation has been enacted that has fundamentally changed the New Mexico Medical Malpractice Act. These new laws significantly alter the way medical malpractice cases are tried, the amount of damages that can and will be awarded, and the funding and management of the state’s Patient Compensation Fund (PCF). In turn, these new laws directly impact the availability and affordability of medical liability insurance for New Mexico’s healthcare professionals.

Professional Education
Breast Cancer Claims: A Review for Advanced Practice Clinicians
Breast cancer medical negligence claims are reviewed over a 10-year period to identify the major case types in which the gynecologist is the responsible party. The factors that contributed to those claims as identified by plaintiff and defense physician experts are discussed through case examples with learner questions. Risk mitigation strategies are identified to guide gynecologists in further providing the safest patient care and thereby improving their risk profile.

Mar 07, 2023
Primary Care Innovations Can Deepen the Specialty
Megan Mahoney, MD, MBA, Professor and Chair, UCSF Department of Family and Community Medicine and Member, The Doctors Company Board of Governors
Dr. Megan Mahoney outlines ways that team-focused innovations in care models and technologies can help preserve depth in primary care, even as it faces a physician shortage.
From The Doctor’s Advocate

Exclusively Endorsed by the American Society of Plastic Surgeons
The American Society of Plastic Surgeons exclusively endorses The Doctors Company. ASPS members receive unique benefits, including exclusive program discounts and credits.

Exclusively Sponsored by the American Association of Neurological Surgeons
The American Association of Neurological Surgeons exclusively sponsors The Doctors Company. AANS members receive unique benefits, including exclusive program discounts and credits.